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Introduction: Metformin is one of the most used oral antidiabetic agents. Intentional and 
unintentional overdose of metformin can be associated with life threatening condition. In 
this study we evaluate prognostic factors for metformin intoxication.  
Methods and Results: This case-control study was performed on patients referred to 
Loghman Hakim toxicology emergency department due to metformin intoxication. The 
patients’ information and lab data were subsequently extracted from their medical file 
and data processing and analysis performed. There was a significant difference between 
two groups in multiple items, patients who died had older age, higher blood sugar, BUN, 
Cr, PT, INR, and WBC, on the other hand this group had lower blood pressure, O2 
saturation, pH, HCO3 and PTT. Receiver operating characteristic curve showed that five 
items including: Bp, O2sat, pH, HCO3 and Cr had the ability to predict the risk of 
mortality in patients with metformin poisoning. Univariate as well as multivariate 
analysis showed that factors including: BP<95 (P=0.0184), O2sat<93 (P=0.0094), 
pH<6.94 (P0.0032), HCO3<17.25 (P=0.0302), and Cr>1.15 (P=0.0216) were related to 
patient’s mortality. 
Conclusion: Our study showed that mentioned clinical and laboratory findings may 
have an important role in determining the prognosis of patients with metformin 
poisoning. Extracorporeal treatments may be considered sooner in those who have poor 
prognostic factors since admission. 
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Metformin, a member of the biguanide family, is one of 
the most used oral antidiabetic agents and the first-line 
treatment of type 2 diabetes mellitus (DM) [1]. 
Metformin reduces microcirculatory complications in 
type 2 diabetic patients and is widely used around the 
world[2]. Metformin promotes euglycemia but it is 
unlikely to cause hypoglycemia when used alone [3]. It 
can enhance the suppression of gluconeogenesis without 
increasing insulin secretion, reduce glucagon-stimulated 
gluconeogenesis, and increase uptake of glucose by 
muscle and adipose cells [4]. Metformin is a first-line 
treatment for diabetes that is used alone or in 
combination with other anti-diabetic medications [3]. 
The most important toxicity of metformin is lactic 
acidosis [5]. metformin promotes the conversion of 
glucose to lactate in the splanchnic bed of the small 
intestine, and it also inhibits mitochondrial respiratory 
chain complex 1, leading to decreased hepatic 
gluconeogenesis from lactate, pyruvate, and alanine [6]. 
Although in the absence of acute overdose, metformin-
associated lactic acidosis (MALA) is very rare, but it has 
a high mortality rate [7, 8]. In overdose conditions, this 
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complication can occur with more incidence and severity 
[9, 10]. The aim of this study was to evaluate the 
prognostic factors of patients with accidental or 
intentional metformin poisoning. 
 
2. Materials & Methods 
 
This case-control study was performed in two phases; 
retrospective and prospective. In the retrospective 
section (which was a 5-year period), all patients who had 
referred to the Loghman Hakim toxicology emergency 
department due to metformin intoxication between April 
2014 and April 2019 have been enrolled. In the 
prospective section, all metformin-poisoned patients who 
have been referred to Loghman Hakim toxicology 
emergency department between April 2019 and April 
2020- with the history of metformin intoxication and 
signs and symptoms including hypoglycemia, lactic 
acidosis, and a rise in blood urea nitrogen were included 
in the study. Patients with previous acute or chronic 
renal dysfunction, and those who took other life-
threatening drugs along with metformin were excluded 
from the study. Then patients were followed to see their 
final outcome (death versus complete recovery). The 
patients’ information and lab data were subsequently 
extracted from their medical file and a specific code was 
assigned to each patient. Data were collected in excel file 
and divided into two subgroups: survived group and non-
survived group. 
The manuscript has been drafted and prepared according 
to the STROBE Statement. 
 
Ethics approval and consent to participate: 
 
This study was evaluated by the Shahid Beheshti 
University of Medical Sciences ethics committee and 
approved with IR.SBMU.RETECH.REC.1398.427 
reference code. Written informed consent was obtained 
from the patients to use all the obtained data for research 
and publication purposes. For the deceased, written 
consent was obtained from their family to use all the 




Statistical analysis was done by SPSS software version 
22 (Chicago, Ill, USA). The data was expressed as mean 
± SD for continuous or discrete variables and as 
frequency and percentage for categorical variables. Chi-
square test was used for statistical analysis of qualitative 
variables. The statistical comparison was done using 
independent student's t-test for comparison of the two 
groups (survivors and died). Logistic regression was 
used to evaluate the predictive factors of mortality. The 
best cut off points were determined by calculating the 
area under the receiver operating characteristics (ROC) 
curve. P values of 0.05 or less were considered to be 
statistically significant, and data was presented with a 
95% confidence interval (CI). 
 
Study limitation: 
The most important limitation of this study was small 




A total of 44 patients have been included in the study. 
Most of the patients were female and minority of them 
were male. There was not difference between survived 
and deceased groups in male to female ratio. There was a 
significant difference between two groups in multiple 
items, patients in deceased group had higher age, blood 
sugar, BUN, Cr, PT, INR, WBC, on the other hand this 
group had lower blood pressure, O2 saturation, pH, 
HCO3 and PTT (Table 1).  
Receiver operating characteristic (ROC) curve showed 
that five items including: Bp, O2sat, pH, HCO3 and Cr 
had ability to predict the risk of mortality in patients with 
metformin poisoning (Figure 1), area under the ROC 
curve and the best cut off points was as following: 
BP<95 [AUC= 0.957 (95% CI: 0.885-1.000)], O2sat<93 
[AUC= 0.808 (95% CI: 0.478-1.000)], PH<6.94 [AUC= 
0.812 (95% CI: 0.504-1.000)], HCO3<17.25 [AUC= 
0.974 (95% CI: 0.920-1.000)], and Cr>1.15 [AUC= 




Figure 1.  ROC curve of predictors of mortality. 
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Table 1. Clinical characteristics of patients with metformin positioning, stratified by survived patients versus died patients 
 All patients ± SD Survived ± SD Died ± SD P value 
Age 29.39 ± 11.62 27.66 ± 12.33 53 ± 17.06 0.0016* 
Male/female 5/39 4/37 1/2 0.3100 
Dose gr 12.11 ± 15.65 12.16 ± 11.76 10 ± 0 0.7545 
PR 89.48 ± 3.229 89.93 ± 17.12 83.33 ± 7.572 0.5149 
BP 115.2 ± 0.3037 117.3 ± 13.64 86.67 ± 15.28 0.0006* 
RR 15.6 ± 2.203 15.49 ± 3.241 17.33 ± 3.055 0.3453 
T 37 ± 29.5 36.98 ± 0.2509 37.27 ± 0.7506 0.1119 
O2sat 97.16 ± 0.1271 97.5 ± 1.569 92.67 ± 4.619 <0.0001* 
BS 103.1 ± 8.961 100.7 ± 26.79 136.3 ± 50.77 0.0419* 
PH 7.304 ± 4.49 7.328 ± 0.06182 6.97 ± 0.3032 <0.0001* 
PCO2 38.01 ± 11.02 38.48 ± 8.816 31.67 ± 10.37 0.2075 
HCO3 19.54 ± 0.6984 20.3 ± 3.178 9.167 ± 7.63 <0.0001* 
BUN 23.05 ± 2.746 22.12 ± 8.562 35.67 ± 29.77 0.0382* 
Cr 1.188 ± 0.3699 1.06 ± 0.3395 2.9 ± 1.808 <0.0001* 
Na 139.6 ± 95.65 139.7 ± 2.762 139.3 ± 3.055 0.8457 
K 4.111 ± 15.4 4.09 ± 0.3534 4.4 ± 0.5568 0.1641 
CPK 133.4 ± 14.82 132.9 ± 95.43 138.7 ± 119.6 0.9224 
AST 28.67 ± 0.907 28.48 ± 15.91 31.33 ± 5.508 0.7606 
ALT 25.53 ± 4.961 25.95 ± 15.26 20 ± 4.359 0.5089 
PT 13.13 ± 0.1413 13.02 ± 0.7341 14.67 ± 1.724 0.0015* 
PTT 35.37 ± 5.205 35.64 ± 4.836 31.8 ± 6.35 0.2002 
INR 1.113 ± 0.3044 1.101 ± 0.1282 1.27 ± 0.2427 0.0446* 
WBC 10.6 ± 1.407 10.08 ± 4.736 17.73 ± 7.222 0.0122* 
RBC 4.392 ± 80.15 4.404 ± 0.3081 4.257 ± 0.2676 0.4290 
HB 13.45 ± 35.26 13.46 ± 1.434 13.33 ± 1.21 0.8789 
PLT 260.9 ± 11.62 263.2 ± 68.86 232.2 ± 200.7 0.5254 
ALKP 187.2 ± 16.68 185.1 ± 35.77 211.5 ± 19.09 0.3192 
 
Univariate analysis showed hypotension, low O2 
saturation, acidosis, rise of Cr, older age, need for 
hemodialysis and need for bicarbonate therapy may be 
associated with poorer prognosis (Table 2). Multivariate 
analysis results strong association between five factor 
and mortality in patients with metformin poisoning 
which presented in Table 3. 
 
 
Table 2. Variable that possible influence the survival of patients with 
metformin intoxication: univariate analysis. 
Variable Score P value 
BP<95 12.914 0.000 
O2sat<93 18.151 0.000 
PH<6.94 28.635 0.000 
HCO3<17.25 12.914 0.000 
Cr>1.15 7.677 0.006 
Age 9.339 0.002 
Underwent Extracorporeal removal  6.149 0.013 
Underwent bicarbonate therapy 32.195 0.000 
 
 
Table 3. Variable that significantly influence the survival of patients 
with metformin intoxication: multivariate analysis 
























Cr>1.15 0.000 (0.000 to 0.4358) 0.0216 
Underwent bicarbonate 
therapy 




4. Discussion and Conclusion 
 
Although metformin is considered a safe medication for 
the treatment of diabetes, overdose with metformin can 
be serious and fatal [11]. Every patient presenting to the 
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emergency department after a suspected metformin 
ingestion should undergo cardiopulmonary monitoring 
for a minimum of 4 to 6 hours [12]. Determination of the 
patients’ prognosis since presentation is a critically 
important factor in patient management in settings with 
limited ICU beds as the clinical toxicology setting [13]. 
Based on our findings, age had a significant prognostic 
value; patients with higher age had poorer prognosis, 
which is consistent with other studies [2]. In general, 
elderly patients has higher mortality in poisoning [14]. 
Higher blood pressure in the survived group and a 
significant difference with the non-survived group 
indicate the effects of hypotension on the poor prognosis 
of patients. Studies have not specifically addressed the 
prognostic effect of hypotension, but in case reports, 
cases with low blood pressure have a worse prognosis 
[15]. In this study, high blood sugar was associated with 
a worse prognosis that had not been studied in 
prognostic studies but in a review, patients with 
hyperglycemia after metformin intoxication also were 
more at the risk of death [16]. O2 saturation in non 
survivors was significantly lower than survivors that 
could be because of severity in poisoning and 
impairment in global oxygen extraction [17]. Other 
factors including: blood pH, serum Cr, Prothrombin time 
and INR were significantly different between two groups 
which is consistent with other studies [2]. Interestingly 
there was no difference between two groups in serum 
potassium despite other studies [2]. In the study of 
univariate as well as multivariate showed, factors 
including: BP<95, O2sat<93, pH<6.94, HCO3<17.25, 
and Cr>1.15 were closely related to patient’s mortality. 
Our study showed that a number of laboratory and 
clinical factors play an important role in determining the 
prognosis of patients with metformin poisoning. 
Extracorporeal treatments may be considered sooner in 
those who have poorer prognostic factors since 
admission. With the evaluation of the cut of points, it can 
be observed that any condition that increases acidosis, 
increases the risk of mortality, and any condition that 
reduces acidosis, such as high respiratory rates and more 
oxygenation and acid washout reduces the risk of 
mortality. In our evaluation, older age, mean blood 
pressures under 95, oxygen saturations below 93%, 
bicarbonate levels below 17.75 meq/L, creatinine levels 
higher than 1.15 mg/dL and levels under 6.94 were 
found to be associated with poor prognosis. 
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